The Business of biotechnology : from the bench to the street

The Business of Biotechnology: From the Bench to the Street clearly addresses the most often asked questions about today's competitive outlook in this rapidly advancing field. As a snapshot of current issues and opportunities in commercial biotechnology, this volume will also prove to be a reference tool of lasting practical value to entrepeneurs, managers, consultants, and related service providers Content: Inside Front Cover , Page ii Front Matter , Page iii Copyright , Page iv Dedication , Page v CONTRIBUTING AUTHORS , Pages xi-xviii FOREWORD , Pages xix-xx PREFACE , Pages xxi-xxii CHAPTER 1 - MIRACLES AND MONEY: THE EVOLUTION OF A NEW INDUSTRY , Pages 1-22 CHAPTER 2 - CAPITALIZING ON NEW OPPORTUNITIES: ENTREPRENEURSHIP IN BIOTECHNOLOGY , Pages 23-37 CHAPTER 3 - THE LIFEBLOOD OF BIOTECHNOLOGY: UNIVERSITY–INDUSTRY TECHNOLOGY TRANSFER , Pages 39-75 CHAPTER 4 - THE SEARCH FOR DOLLARS: LIFE CYCLE OF A BIOTECHNOLOGY COMPANY , Pages 77-89 CHAPTER 5 - FUELING DREAMS INTO REALITIES: A VENTURE CAPITALIST'S PERSPECTIVE , Pages 91-103 CHAPTER 6 - GROWING THE ORGANIZATION: PEOPLE-POWER FROM RESEARCH AND DEVELOPMENT START-UP TO MARKET-DRIVEN ENTERPRISE , Pages 105-115 CHAPTER 7 - HOPE IN THE VIAL: THE CLONING AND EXPRESSION OF RECOMBINANT PRODUCTS , Pages 117-138 CHAPTER 8 - SCIENCE, TECHNOLOGY, AND POLITICS: REAL FACTORS IN SELECTING A MAMMALIAN CELL BIOREACTOR , Pages 139-150 CHAPTER 9 - THE PROTECTION OF INTELLECTUAL PROPERTY IN BIOTECHNOLOGY , Pages 151-167 CHAPTER 10 - IMPACT OF GOVERNMENT REGULATION ON COMMERCIAL BIOTECHNOLOGY , Pages 169-198 CHAPTER 11 - BIOTECHNOLOGY AND THE U.S. GOVERNMENT: THE POT AT THE END OF THE RAINBOW? , Pages 199-211 CHAPTER 12 - OURS, THEIRS OR BOTH? STRATEGIC PLANNING AND DEAL MAKING , Pages 213-224 CHAPTER 13 - IN THE TRENCHES: THE MARKETING AND SELLING OF BIOTECHNOLOGY , Pages 225-248 CHAPTER 14 - CREATING AND MARKETING THE IMAGE OF THE BIOTECHNOLOGY COMPANY , Pages 249-259 CHAPTER 15 - WALL STREET AND BIOTECHNOLOGY: A WALK ON THE WILDER SIDE , Pages 261-271 CHAPTER 16 - MERGERS AND ACQUISITIONS WITHIN THE BIOTECHNOLOGY INDUSTRY , Pages 273-293 CHAPTER 17 - JAPAN'S DILEMMA: WHERE AND WHEN? , Pages 295-317 CHAPTER 18 - EUROPHORIA: BIOPHARMACEUTICALS IN THE EMERGING EUROPEAN MARKET , Pages 319-344 CHAPTER 19 - BIOTECHNOLOGY MEGATRENDS: LESSONS FROM THE PAST—VISIONS OF THE FUTURE , Pages 345-363 INDEX , Pages 365-369 The Business of Biotechnology: From the Bench to the Street thoroughly examines the existing and future business challenges for biotechnology, providing a unique insight into the intricate web of critical factors with which biotechnology entrepreneurs must come to terms if they wish to be successful. The book begins with discussions of the evolution of biotechnology; entrepreneurship in the biotechnology industry; university-industry technology transfer process; and the life cycle of a biotechnology company. It considers the prospects for biotechnology, from the perspective of a venture capitalist and human resource practitioner. There are separate chapters that deal with the cloning and expression of recombinant gene products; developing strategies to reduce the cost-to-produce (CTP) therapeutic proteins; intellectual property protection; and the regulation of commercial biotechnology. The final chapters cover the marketing of biotechnology companies and products; the performance of biotechnology stocks; mergers and acquisitions in the biotechnology industry, and prospects for the Japanese and European biotechnology industry.